Sarepta Therapeutics
SRPT
SRPT
132 hedge funds and large institutions have $680M invested in Sarepta Therapeutics in 2016 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 56 increasing their positions, 34 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
38% less capital invested
Capital invested by funds: $1.1B → $680M (-$420M)
48% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 40
Holders
132
Holding in Top 10
4
Calls
$86.6M
Puts
$85.3M
Top Buyers
| 1 | +$31.1M | |
| 2 | +$22.6M | |
| 3 | +$16.9M | |
| 4 |
TCP
Tourbillon Capital Partners
New York
|
+$15.7M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$13.8M |
Top Sellers
| 1 | -$32.4M | |
| 2 | -$17.5M | |
| 3 | -$11M | |
| 4 |
Renaissance Technologies
New York
|
-$7.28M |
| 5 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$5.37M |